Therapeutic Epigenetic Reprogramming of Trained Immunity in Myeloid Cells

Trends Immunol. 2019 Jan;40(1):66-80. doi: 10.1016/j.it.2018.11.006.

Abstract

Infiltrating and tissue-resident myeloid cells are essential regulators of innate and adaptive immunity. During inflammation, and in response to microbial products, these cells can adapt to microenvironmental conditions and acquire specialized functions, including phagocytosis and the production of proinflammatory cytokines. Such myeloid plasticity is driven, in part, by epigenetic dynamics that can sustain stable phenotypes after activation, and which may lead to maladaptive cell polarization states associated with inflammation and autoimmunity. Here, we review recent reports describing epigenetic mechanisms linked to such polarization states and innate immune memory (tolerance and training) in monocyte and macrophage lineages. We discuss how these mechanisms might be targeted to develop putative immunomodulatory tools that might be used to treat a variety of immune-mediated diseases.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Epigenesis, Genetic / drug effects*
  • Epigenesis, Genetic / genetics
  • Epigenesis, Genetic / immunology
  • Humans
  • Immunity, Innate / drug effects*
  • Immunity, Innate / immunology
  • Immunologic Factors / immunology
  • Immunologic Factors / therapeutic use*
  • Immunologic Memory / drug effects*
  • Immunologic Memory / immunology
  • Myeloid Cells / drug effects*
  • Myeloid Cells / immunology

Substances

  • Immunologic Factors